New antiplatelet agents and anticoagulants in light of ES quidelines 2012 for the treatment of patients with acute ST-segment elevation myocardial infarction

Abstract

The new recommendations of the European Society of Cardiology (EKS) of 2012 concerning the pharmacotherapy of patients with acute myocardial infarction with ST-segment elevation summarize new findings on antiplatelet and anticoagulant therapy

Keywords

• antiplatelet
• anticoagulants
• pharmacotherapy, acute ST-segmen
• myocardial infarction